Physician profile
Rita Glor
NPI 1033175211
$1,627.14
in general payments reported to CMS, 2019-2025
19 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $380 · 2021: $255 · 2022: $172 · 2023: $126 · 2024: $208 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $493.93 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.52 | 2021-2025 | Jardiance |
| Edwards Lifesciences Corporation | $116.07 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $115.06 | 2021-2022 | |
| Novo Nordisk INC | $110.09 | 2019-2025 | Ozempic |
| Amgen INC. | $95.08 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.43 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $51.82 | 2019 | |
| Redhill Biopharma INC. | $46.81 | 2022-2024 | Talicia |
| Allergan, INC. | $40.00 | 2019 | |
| Lilly USA, LLC | $38.69 | 2021-2022 | |
| Horizon Therapeutics Plc | $28.03 | 2022 | |
| Abbvie INC. | $23.44 | 2021 | |
| Radius Health, INC. | $22.95 | 2019 | |
| Merck Sharp & Dohme LLC | $18.12 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $17.67 | 2023 | Farxiga |
| Kowa Pharmaceuticals America, INC. | $17.15 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.97 | 2019 | |
| Exact Sciences Corporation | $13.31 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Glor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.